Hospital
Avera Holy Family
Avera Holy Family was paid $488K by Medicaid between Jan 2018 and Nov 2024, across 39 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 16% of everything it billed.
33Billing provider infoAVERA HOLY FAMILY
ESTHERVILLE, IA 51334
ESTHERVILLE, IA 51334
33aNPI1508810177assigned 05/19/2006
33bProvider typeCritical Access Hospital
28Total paid$488K
24GClaims13,974
24DCodes billed39
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Iowa
Rank by total paid#54 of 79
Median peer was paid$801K
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,520 | $81K | |
| 2019 | 2,149 | $53K | |
| 2020 | 1,349 | $43K | |
| 2021 | 1,723 | $49K | |
| 2022 | 2,313 | $81K | |
| 2023 | 1,490 | $62K | |
| 2024incomplete | 1,430 | $118K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 16% | 5,967 | 4,759 | $80K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 465 | 394 | $60K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 10.0% | 260 | 250 | $49K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 9.8% | 759 | 729 | $48K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.0% | 124 | 99 | $44K |
| 80053 | Comprehensive metabolic panel | 8.2% | 951 | 816 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.1% | 1,264 | 1,057 | $39K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.4% | 424 | 378 | $31K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.6% | 172 | 162 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 186 | 171 | $13K |
| J3490 | Unclassified drugs | 2.4% | 701 | 312 | $12K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.9% | 22 | 14 | $9K |
27 more codes
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 827 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 332 | $6K |
| 81001 | 1.1% | 336 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 103 | $4K |
| 80061 | Lipid panel | <1% | 131 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 137 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 50 | $3K |
| 87631 | <1% | 18 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 27 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 32 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 56 | $1K |
| 82607 | <1% | 28 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 33 | $1K |
| 84439 | <1% | 29 | $836.26 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 31 | $823.40 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $639.40 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 16 | $480.58 |
| 85027 | <1% | 18 | $464.82 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 15 | $386.96 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 105 | $367.37 |
| 84550 | <1% | 13 | $244.17 | |
| 85014 | <1% | 18 | $202.38 | |
| 85018 | <1% | 18 | $202.38 | |
| 36416 | <1% | 13 | $121.56 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 16 | $19.44 |
| A9270 | Non-covered item or service | 0% | 251 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERZBERG, DEB (CEO)
| Provider | Location | Paid |
|---|---|---|
| Avera Holy Family | Estherville, IA | $433K |
| Avera Holy Family | Estherville, IA | $48K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.